{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:42:39Z","timestamp":1770979359753,"version":"3.50.1"},"reference-count":16,"publisher":"Hindawi Limited","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3217,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01208.x","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T11:24:25Z","timestamp":1163157865000},"page":"1530-1535","source":"Crossref","is-referenced-by-count":10,"title":["Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet"],"prefix":"10.1155","volume":"60","author":[{"given":"G.","family":"SHAPERO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"DOWSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"LACOSTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"ALMQVIST","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,11,10]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1185\/1723305X56659","article-title":"Primary care needs assessment for guidance on headache management","volume":"2","author":"Dowson","year":"2005","journal-title":"Headache Care"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB2|cit2","first-page":"47","article-title":"There is a strong unmet need for improved headache education among primary care physicians: results from a primary care needs assessment","volume":"2","author":"Kern","year":"2005","journal-title":"Headache Care"},{"issue":"Suppl. 7","key":"10.1111\/j.1742-1241.2006.01208.x-BIB3|cit3","first-page":"S1","article-title":"Headache classification subcommittee","volume":"8","author":"International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","article-title":"Migraine diagnosis and treatment: results from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1526-4610.2003.03004.x","article-title":"Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey","volume":"43","author":"MacGregor","year":"2003","journal-title":"Headache"},{"issue":"6 Suppl. 1","key":"10.1111\/j.1742-1241.2006.01208.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1212\/WNL.56.suppl_1.S29","article-title":"Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice","volume":"56","author":"Edmeads","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1185\/030079904X10142","article-title":"Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey - phase IV","volume":"20","author":"MacGregor","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0317167100052525","article-title":"Systematic review of the use of triptans in acute migraine","volume":"28","author":"Gawel","year":"2001","journal-title":"Can J Neurol Sci"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1526-4610.2003.03067.x","article-title":"Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting","volume":"43","author":"Gibbs","year":"2003","journal-title":"Headache"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2006.01208.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.48.3_Suppl_3.16S","article-title":"The doctor and the migraine patient: improving compliance","volume":"48","author":"MacGregor","year":"1997","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10194-005-0164-3","article-title":"Patients\u2019 preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine","volume":"6","author":"Dowson","year":"2005","journal-title":"J Headache Pain"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"International Headache Society clinical trials subcommittee. Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1185\/1723305X75171","article-title":"ZAP primary care programme: headache education through clinical experience","volume":"2","author":"Almqvist","year":"2005","journal-title":"Headache Care"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.2002.00319.x","article-title":"Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine","volume":"22","author":"Dowson","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1742-1241.2006.01208.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2165\/00023210-200418150-00007","article-title":"Acute treatment of migraine with zolmitriptan 5\u2003mg orally disintegrating tablet","volume":"18","author":"Spierings","year":"2004","journal-title":"CNS Drugs"},{"issue":"Suppl. 3","key":"10.1111\/j.1742-1241.2006.01208.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1185\/030079905X46278","article-title":"Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine","volume":"21","author":"Loder","year":"2005","journal-title":"Curr Med Res Opin"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01208.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:43Z","timestamp":1643349883000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01208.x"}},"subtitle":["ZOLMITRIPTAN AND IMPROVED MIGRAINE MANAGEMENT IN PRIMARY CARE"],"short-title":[],"issued":{"date-parts":[[2006,11,10]]},"references-count":16,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01208.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11,10]]}}}